Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.KR |
First Approval Date03 Dec 2024 |
100 Clinical Results associated with DIDBIO Co.,Ltd
0 Patents (Medical) associated with DIDBIO Co.,Ltd
100 Deals associated with DIDBIO Co.,Ltd
100 Translational Medicine associated with DIDBIO Co.,Ltd